首页> 外文OA文献 >Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials.
【2h】

Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials.

机译:大米基口服补液对大便量和腹泻持续时间的影响:13项临床试验的荟萃分析。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVE--To define the benefit of rice oral rehydration salts solution in relation to the glucose based World Health Organisation oral rehydration salts solution for treating and preventing dehydration in patients with severe dehydrating diarrhoea. DESIGN--Meta-analysis using data from 13 available randomised trials that compared these two formulations. SUBJECTS--The studies compared 1367 patients with cholera, severe cholera-like diarrhoea, or acute non-cholera diarrhoea. 668 received the standard WHO solution and 699 the rice based solution. INTERVENTION--Each trial report was reviewed to determine patient eligibility, the number of patients who were randomised and the number of these excluded from analysis, details of the randomisation procedure, and the precise timing of the outcome measurements. MAIN OUTCOME MEASURES--Stool output during the first 24 hours; weighted estimates of the difference in mean stool output between treatments. RESULTS--The rice solution significantly reduced the rate of stool output during the first 24 hours by 36% (95% confidence interval 28 to 44%) in adults with cholera and by 32% (19 to 45%) in children with cholera. The rate of stool loss in infants and children with acute non-cholera diarrhoea was reduced by only 18% (6 to 30%). CONCLUSIONS--The benefit of rice oral rehydration salts solution for patients with cholera is sufficiently great to warrant its use in such patients. The benefit is considerably smaller for children with acute, noncholera diarrhoea and should be more precisely defined before its practical value can be judged.
机译:目的-定义大米口服补液盐溶液相对于基于葡萄糖的世界卫生组织口服补液盐溶液在治疗和预防重度腹泻患者脱水中的益处。设计-使用来自13个可用随机试验的数据进行元分析,将这两种配方进行比较。受试者-研究比较了1367例霍乱,严重霍乱样腹泻或急性非霍乱腹泻患者。 668接受了标准的WHO溶液,699接受了基于大米的溶液。干预措施-审查每个试验报告以确定患者的资格,被随机分组​​的患者人数以及从分析中排除的这些患者人数,随机化程序的详细信息以及结果测量的准确时机。主要观察指标-前24小时的排便量;两次治疗之间大便平均产量差异的加权估计。结果-在霍乱成人中,大米溶液在头24小时内显着降低了大便排出率,降低了36%(95%置信区间为28至44%),而霍乱儿童降低了32%(19至45%)。急性非霍乱腹泻的婴幼儿粪便流失率仅降低了18%(6%至30%)。结论-稻米口服补液盐溶液对霍乱患者的益处非常巨大,足以保证在此类患者中使用它。对于患有急性,非霍乱性腹泻的儿童而言,这种益处要小得多,因此在判断其实际价值之前应更精确地定义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号